Monthly Archives: March 2020
I keep my ear to the ground on issues regarding board certification to make sure anyone who is taking an exam is in the loop! If you are taking any of the BPS exams in the Spring, be aware that you can pick a new date as the testing period has been extended to June […]
Read More
Fluvoxamine drug interactions can be clinically significant in clinical practice. It is a major reason why this medication is not used very often. If you ever see it on a medication list of one of your patients, you must do a drug interaction screen. According to the package insert, fluvoxamine can inhibit CYP1A2, CYP2C9, CYP3A4, […]
Read More
The world is a buzz with COVID-19 news and rightfully so. I want to cover hydroxychloroquine clinical pearls. This drug has been purported to have activity against coronavirus. Here’s a link to that research article. Uses of Hydroxychloroquine While it is classified as an antimalarial agent, the most common, long term use for hydroxychloroquine that […]
Read More
I’m seeing this article all over the place recommending to avoid NSAIDs in patients who have an infection with the new COVID-19 coronavirus. My question is, where’s the evidence? The only thing I can find is that it was based upon is a scientific theory as well as data that NSAIDs may not be good […]
Read More
Hey all, thanks so much for supporting the blog as well as the podcast! I’m amazed at how many people come to pick up a few pearls or listen to the drug of the week. Because of your support, I like to give annual sweet deals on our content! Today is the day for our […]
Read More